FDA extends approval deadline for Valneva’s chikungunya vaccine by 3 months | Healio

Though malaria has received increased attention recently following new cases in the US, many other mosquito-borne illness, including chikungunya, are still a concern globally. CEID faculty Dr. David Hamer offers his perspective on why a forthcoming vaccine for this virus is important. Read more here.